Negative predictors of clinical response to triptans in patients with migraine

Neurological Sciences

Volumn 33, Issue 2, 2012, Pages 453-461

  Ishii, M ^a   Sakairi, Y ^a   Hara, H ^a   Imagawa, A ^a   Shimizu, S ^a   Takahashi, J ^a   Nagamine, A ^a   Naito, Y ^a   Masuda, Y ^a   Usami, S ^a,b   Kiuchi, Y ^a  

^a SHOWA UNIVERSITY   (Japan)

^b Usami Neurosurgery Clinic/Institute   (Japan)

Author keywords

Clinical response; Migraine; Risk factor; Triptan

Indexed keywords

CYTOSINE; DOPAMINE 2 RECEPTOR; ELETRIPTAN; GUANINE; NARATRIPTAN; RIZATRIPTAN; SEROTONIN 5 HT 1B RECEPTOR; SEROTONIN 5 RECEPTOR; SUMATRIPTAN; THYMINE; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; ZOLMITRIPTAN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DEEP ORBITAL PAIN; DNA POLYMORPHISM; DRUG RESPONSE; EXTRAVERSION; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NUCLEOTIDE SEQUENCE; ORBIT DISEASE; PERIORBITAL PAIN; PERSONALITY; PREDICTION; SCORING SYSTEM; SENSITIVITY AND SENSIBILITY; SLEEP DISORDER; STRESS; VALIDITY;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MINISATELLITE REPEATS; PERSONALITY; PERSONALITY INVENTORY; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RECEPTORS, DOPAMINE D2; RECEPTORS, SEROTONIN; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEROTONIN ANTAGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STATISTICS, NONPARAMETRIC; TRYPTAMINES; YOUNG ADULT;

EID: 84863989919     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0716-z     Document Type: Article

References (43)

1. Diener HC, Limmroth V (2001) Advances in pharmacological treatment of migraine. Expert Opin Investig Drugs 10:1831-1845 (Pubitemid 32990017)
2. Maassen Van Den Brink A, Vergouwe MN, Ophoff RA, Saxena PR, Ferrari MD, Frants RR (1998) 5-HT1B receptor polymorphism and clinical response to sumatriptan. Headache 38:288-291 (Pubitemid 28194302)
3. Asuni C, Cherchi A, Congiu D, Piccardi MP, Del Zompo M, Stochino ME (2007) Association study between clinical response to rizatriptan and some candidate genes. J Headache Pain 8:185-189 (Pubitemid 47062591)
4. Schurks M, Kurth T, Stude P, Rimmbach C, de Jesus J, Jonjic M, Diener HC, Rosskopf D (2007) G protein b3 polymorphism and triptan response in cluster headache. Clin Pharmacol Ther 82:396-401 (Pubitemid 47414346)
5. Terrazzino S, Viana M, Floriddia E, Monaco F, Mittino D, Sances G, Tassorelli C, Nappi G, Rinaldi M, Canonico PL, Genazzani AA (2010) The serotonin transporter gene polymorphism STin2 VNTR confers an increased risk of inconsistent response to triptans in migraine patients. Eur J Pharmacol 641:82-87
6. Diener HC, Ferrari M, Mansbach H, SNAP Database Study Group (2004) Predicting the response to sumatriptan: the Sumatriptan Naratriptan Aggregate Patient Database. Neurology 63:520-524 (Pubitemid 39031384)
7. Diener HC, Dodick DW, Goadsby PJ, Lipton RB, Almas M, Parsons B (2007) Identification of negative predictors of pain-free response to triptans: analysis of the eletriptan database. Cephalalgia 28:35-40 (Pubitemid 350212650)
8. Amanzio M, Corazzini LL, Vase L, Benedetti F (2009) A systematic review of adverse events in placebo groups of antimigraine clinical trials. Pain 146:261-269
9. Vase L, Robinson ME, Verne GN, Price DD (2005) Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 115:338-347 (Pubitemid 40725290)
10. Mitsikostas DD (2009) Nocebo effect in headache treatment. Cephalalgia 29:176
11. Drici MD, Raybaud F, De Lunardo C, Iacono P, Gustovic P (1995) Influence of the behaviour pattern on the nocebo response of healthy volunteers. Br J Clin Pharmacol 39:204-206
12. Geers AL, Helfer SG, Kosbab K, Weiland PE, Landry SJ (2005) Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response. J Psychosom Res 28:121-127
13. Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9-160
14. Costa PT Jr, McCrae RR (1992) Revised NE Opersonality inventory (NEO-PI-R) and NEO five-factor inventory (NEO-FFI) professional manual. Psychological Assessment Resources, Odessa
15. Murakami F, Shimomura T, Kotani K, Ikawa S, Nanba E, Adachi K (1999) Anxiety traits associated with a polymorphism in the serotonin transporter gene regulatory region in the Japanese. J Hum Genet 44:15-17 (Pubitemid 29058525)
16. Kaiser R, Muller-Oerlinghausen B, Filler D, Tremblay PB, Berghofer A, Roots I, Brockmoller J (2002) Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporter. Am J Med Genet 114:323-328 (Pubitemid 34258860)
17. Joober R, Benkelfat C, Brisebois K, Toulouse A, Turecki G, Lal S, Bloom D, Labelle A, Lalonde P, Fortin D, Alda M, Palmour R, Rouleau GA (1999) T102 polymorphism in the 5-HT2A gene and schizophrenia: relation to phenotype and drug response variability. J Psychiatry Neurosci 24:141-146
18. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, Nothen MM, Maffei P, Franke P, Fritze J, Maier W, Propping P, Beckmann H, Bellodi L, Lesch KP (1999) Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621-624 (Pubitemid 29139976)
19. Guo G, Ou XM, Roettger M, Shih JC (2008) The VNTR 2 repeat in MAOA and delinquent behavior in adolescence and young adulthood: associations and MAOA promoter activity. Eur J Hum Genet 16:626-634 (Pubitemid 351594130)
20. Hotamisligil GS, Breakefield XO (1991) Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 49:383-392 (Pubitemid 21891684)
21. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers G J H, den Heijer M, Kluijtmans L A J, van den Heuve LP, Rozen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
22. Rigat B, Hubert C, Corvol P, Soubrier F (1992) PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20:1433
23. Colson NJ, Lea RA, Quinlan S, Griffiths LR (2006) No role for estrogen receptor 1 gene intron 1 Pvu II and exon 4 C325G polymorphisms in migraine susceptibility. BMC Med Genet 7:12
24. Curran JE, Lea RA, Rutherford S, Weinstein SR, Griffiths LR (2001) Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer. Int J Cancer 95:271-275 (Pubitemid 32592096)
25. Sarkar G, Kapelner S, Grandy DK, Marchionni M, Civelli O, Sobell J, Heston L, Sommer SS (1991) Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics 11:8-14
26. Asuni C, Stochino ME, Cherchi A, Manchia M, Congiu D, Manconi F, Squassina A, Piccardi MP, Del Zompo M (2009) Migraine and tumour necrosis factor gene polymorphism. An association study in a Sardinian sample. J Neurol 256:194-197
27. Kimura K, Iguchi Y, Shibazaki K, Junya A, Terasawa Y (2008) Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery. J Neurol Sci 272:136-142
28. Kimura K, Iguchi Y, Shibazaki K, Terasawa Y, Aoki J, Matsumoto N (2009) The presence of a right-to-left shunt is associated with dramatic improvement after thrombolytic therapy in patients with acute ischemic stroke. Stroke 40:303-305
29. Lee TC, Wang HP, Chiu HM, Lien WC, Chen MJ, Yu LC, Sun CT, Lin JT, Wu MS (2010) Male gender and renal dysfunction are predictors of adverse outcome in nonpostoperative ischemic colitis patients. J Clin Gastroenterol 44:e96-e100
30. Lang UE, Hellweg R, Gallinat J (2004) BDNF serum concentrations in healthy volunteers are associated with depressionrelated personality traits. Neuropsychopharmacology 29:795-798 (Pubitemid 38402487)
31. Terracciano A, McCrae RR, Brant LJ, Costa PT Jr (2005) Hierarchical linear modeling analyses of the NEO-PI-R scales in the Baltimore Longitudinal Study of Aging. Psychol Aging 20:493-506 (Pubitemid 41572553)
32. Schurks M, Rosskopf D, de Jesus J, Jonjic M, Diener HC, Kurth T (2007) Predictors of acute treatment response among patients with cluster headache. Headache 47:1079-1084 (Pubitemid 47057223)
33. Mulder RT (2002) Personality pathology and treatment outcome in major depression: a review. Am J Psychiatry 159:359-371 (Pubitemid 34184728)
34. Goubert L, Crombez G, Damme SV (2004) The role of neuroticism, pain catastrophizing and pain-related fear in vigilance to pain: a structural equations approach. Pain 107:234-241 (Pubitemid 38083379)
35. Kelman L (2005) Migraine pain location: a tertiary care study of 1283 migraineurs. Headache 45:1038-1047
36. Takeshima T, Ishizaki K, Fukuhara Y, Ijiri T, Kusumi M, Wakutani Y, Mori M, Kawashima M, Kowa H, Adachi Y, Urakami K, Nakashima K (2004) Population-based door-to-door survey of migraine in Japan: the Daisen study. Headache 44:8-19 (Pubitemid 38116657)
37. Chakravarty A, Mukherjee A, Roy D (2008) Migraine pain location: how do children differ from adults? J Headache Pain 9:375-379
38. Sarchielli P, Pini LA, Zanchin G, Alberti A, Maggioni F, Rossi C, Floridi A, Calabresi P (2006) Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders. Cephalalgia 26:257-265
39. Gentile G, Borro M, Lala N, Missori S, Simmaco M, Martelletti P (2010) Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine. J Headache Pain 11:431-435
40. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM, Smith CA (1996) Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 347:731-733 (Pubitemid 26085649)
41. Yu YW, Tsai SJ, Hong CJ, Chen TJ, Chen MC, Yang CW (2005) Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsychopharmacology 30:1719-1723 (Pubitemid 43086029)
42. Walsh BT, Seidman SN, Sysko R, Gould M (2002) Placebo response in studies of major depression: variable, substantial, and growing. JAMA 287:1840-1847 (Pubitemid 34303629)
43. Torelli P, D'Amico D (2004) An updated review of migraine and co-morbid psychiatric disorders. Neurol Sci 25 Suppl 3:S234-S235 (Pubitemid 41462000)